# AI-nasal-drug-delivery
# AI-Assisted Nasal Drug Delivery Optimization

This project demonstrates how AI can support product decision-making in regulated healthcare environments.  
It combines experimental formulation data with AI-assisted reasoning and lightweight predictive modeling to guide formulation selection for nose-to-brain drug delivery.

---

## ðŸ” Problem
Oral antiretroviral therapies show limited CNS penetration due to the bloodâ€“brain barrier, leading to persistent HIV reservoirs in the brain.  
This project explores a non-invasive nasal in-situ gel delivery system supported by AI-driven formulation evaluation.

---

## ðŸ¤– AI Product Prototype
ðŸ‘‰ **Interactive AI Artifact (Claude):**  
ðŸ”— https://claude.ai/public/artifacts/fb9b3ba8-a8ec-4c4d-ae61-3c256e22e329  

The artifact evaluates formulation trade-offs, ranks candidates, and recommends an optimized formulation under safety and performance constraints.

---

## ðŸ§  AI Logic
- AI-assisted reasoning using Claude
- Lightweight predictive model for drug-release estimation
- Human-in-the-loop decision validation

---

## ðŸ“Š Data
Experimental formulation parameters:
- Polymer ratios (Pluronic F127, HPMC E50LV)
- Gelation temperature & time
- Viscosity & pH
- 12-hour drug release %

---

## ðŸ§ª Results
- Optimized formulation achieved >90% sustained release
- Rapid gelation at physiological temperature
- Nasal-compatible pH and safety profile

---

## ðŸ’¼ Business Perspective
- Target customers: Pharmaceutical companies, public health programs
- Value: Faster R&D cycles, improved CNS delivery, better patient adherence
- Monetization: B2B licensing & co-development

---

## ðŸš€ Next Steps
- In-vivo validation
- Expanded dataset & ML model
- Personalized formulation optimization

---

## ðŸ‘¤ Author
**Your Name**  
AI Product Manager | HealthTech
